BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8655369)

  • 1. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
    Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
    J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
    Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
    Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.
    Alsner J; Høyer M; Sørensen SB; Overgaard J
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):519-25. PubMed ID: 11173149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
    Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
    Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.
    Hammond E; Berkey BA; Fu KK; Trotti A; Meredith RF; Jones CU; Byhardt R; Horwitz EM; Ang KK
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):683-92. PubMed ID: 14529772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
    Benazzo M; Mevio E; Occhini A; Franchini G; Danova M
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):39-43. PubMed ID: 7700609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
    Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
    Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter study.
    Antognoni P; Bignardi M; Cazzaniga LF; Poli AM; Richetti A; Bossi A; Rampello G; Barbera F; Soatti C; Bardelli D; Giordano M; Danova M
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1137-45. PubMed ID: 8985036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy.
    Bourhis J; Wilson G; Wibault P; Bosq J; Chavaudra N; Janot F; Luboinski B; Eschwege F; Malaise EP
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):793-9. PubMed ID: 8344848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy.
    Zackrisson B; Gustafsson H; Stenling R; Flygare P; Wilson GD
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):677-83. PubMed ID: 9240632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Dirix P; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer.
    Dobrowsky W; Dobrowsky E; Wilson GD
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):576-82. PubMed ID: 12573744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer.
    Corvò R; Paoli G; Giaretti W; Sanguineti G; Geido E; Benasso M; Margarino G; Vitale V
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):57-63. PubMed ID: 10758305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer.
    Bourhis J; Wilson G; Wibault P; Janot F; Bosq J; Armand JP; Luboinski B; Malaise EP; Eschwege F
    Laryngoscope; 1994 Apr; 104(4):468-72. PubMed ID: 8164487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.
    Beitler JJ; Zhang Q; Fu KK; Trotti A; Spencer SA; Jones CU; Garden AS; Shenouda G; Harris J; Ang KK
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):13-20. PubMed ID: 24613816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
    Haustermans K; Fowler JF
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):505-11. PubMed ID: 11173147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.